Cerus is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Cerus Corporation develops and supplies pathogen-reduction technologies for blood components to ensure blood safety, serving blood centers, hospitals, and patients globally.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.